Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Baricitinib was effective in treating both early and late onset alopecia areata.

The LMNA mutation affects skin structure even in asymptomatic carriers.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Stopping azathioprine improved hair loss and bone marrow issues.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

The gel is safe and effective for treating oral mucositis from chemotherapy and radiation.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

The new formulation improves dutasteride's absorption when taken orally.

Dutasteride microinfusion and microneedling both effectively treat male hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.

Juvenile dermatomyositis can worsen quickly and needs strong treatment.

Methotrexate plus prednisolone had the fewest serious side effects.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

AS101 reduces hair loss from chemotherapy.